Elekta issues a SEK 1 billion bond with five year maturity

STOCKHOLM, March 26, 2015 – Elekta (EKTA-B.ST) has today issued a SEK 1 billion bond, with five year maturity, under its existing Medium Term Note Program with a total limit of SEK 5 billion.

The bond is divided in two tranches (the “Bonds”), fixed and floating. The first tranche of SEK 300 million has a fixed coupon rate of 1.580 percent paid annually and the second tranche of SEK 700 million has a floating interest rate of 3 months STIBOR plus an interest margin of 1.20 percent paid quarterly.

Final terms of the Bonds are available on Elekta’s website www.elekta.com .

Skandinaviska Enskilda Banken (SEB) acted as lead manager for the issue.

# # #

For further information, please contact:
Håkan Bergström, CFO, Elekta AB
Tel: +46 8 587 25 547, e-mail: hakan.bergstrom@elekta.com          
Time zone: CET: Central European Time

Tobias Bülow, Director Financial Communication, Elekta AB
Tel: +46 722 215 017, e-mail: tobias.bulow@elekta.com
Time zone: CET: Central European Time

The above information is such that Elekta AB (publ) shall make public in accordance with the Securities Market Act and/or the Financial Instruments Trading Act. The information was published at 14:00 CET on March 26, 2015.

About Elekta
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both health care providers and patients, Elekta aims to improve, prolong and even save patient lives.

Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,800 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on NASDAQ Stockholm. Website: www.elekta.com .

About Us

Elekta is proud to be the leading innovator of equipment and software used to improve, prolong and save the lives of people with cancer and brain disorders. Our advanced, effective solutions are created in collaboration with customers, and more than 6,000 hospitals worldwide rely on Elekta technology. Our treatment solutions and oncology informatics portfolios are designed to enhance the delivery of radiation therapy, radiosurgery and brachytherapy, and to drive cost efficiency in clinical workflows. Elekta employs 3,600 people around the world. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm. www.elekta.com

Subscribe

Documents & Links